Opioid-use disorder (OUD), a risk factor and major contributor to opioid-related deaths, is often underdiagnosed and undertreated. Currently there are three FDA-approved pharmacologic treatments for OUD maintenance therapy: methadone, buprenorphine (with or without naloxone), and naltrexone. Despite definitive evidence that methadone and buprenorphine products are effective in the treatment of OUD, there are still considerable accessibility and availability barriers that patients face when seeking Medication Assisted Treatment (MAT). The EXtended-release naltrexone vs Buprenorphine/naloxone for Opioid Treatment (X:BOT) trial compared the efficacy and safety of XR-NTX and BUP-NX to induce and maintain a patient with OUD on MAT as well as reducing opioid overdoses, relapses, and cravings.
Guest Author: Jordan L. Wulz, PharmD, MPH, BC-ADM, CHC
Music by Good Talk
Semaglutide for CKD – Does the FLOW trial impact the standard of care?
“We’ed” Better Work Together to Address Cannabis Use in Pregnancy
Remote Patient Monitoring (RPM): The Promise and Pitfalls
An Age-Old Question: Warfarin or a Direct Oral Anticoagulant in Frail Adults?
Complex Patient Case 6: Multiple Comorbidities and Too Many Meds
Weighing Options: Comparing Oral Anticoagulants for Patients at Various BMIs
Managing COPD: 2024 GOLD Guideline Updates and More
Conquering Confusion: Could Metformin Reduce Dementia Risk?
Complex Patient Case 5: Hypoglycemia and a Painful, Swollen Leg
Top Ten Things Every Clinician Should Know About Pharmacogenomics
Driving + Older Adult + Medications = An Accident Waiting to Happen?
Eosinophils Take the Wheel in Steering Steroid Therapy for COPD Exacerbations
SDOH Matters Too! Patient and Care Team Perspectives on Screening for SDOH
Treating Depression and Anxiety: Dosing, Pharmacogenetics, and Our Learners
Complex Patient Case 4: Diabetes, CKD, and Psoriasis
Can Losing Weight Using Semaglutide Prevent a Heart Attack, Ack, Ack, Ack, Ack?
Prescription for Savings: The Clinical and Economic Impact of Pharmacist-Led Hypertension Management in the U.S.
Heartburn Headache: Cumulative PPI Use and Dementia Risk
Does Size Matter? The Surprising Impact of Cuff Size on Blood Pressure Readings
Defining the Role of Semaglutide in Obese Patients with Heart Failure with Preserved Ejection Fraction
Create your
podcast in
minutes
It is Free
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive